1. Predictive Value of Microdose Pharmacokinetics

   • Merel van Nuland
   • Hilde Rosing
   • Jos H. Beijnen

   Review Article 27 April 2019 Pages: 1221 - 1236

   

2. Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update

   • Elise J. Smolders
   • Anouk M. E. Jansen
   • David M. Burger

   Review Article Open access 21 May 2019 Pages: 1237 - 1263

   

3. Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review

   • Wonkyung Byon
   • Samira Garonzik
   • Charles E. Frost

   Review Article Open access 14 May 2019 Pages: 1265 - 1279

   

4. Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016

   • Anitha Saravanakumar
   • Armin Sadighi
   • Fatemeh Akhlaghi

   Systematic Review 10 April 2019 Pages: 1281 - 1294

   

5. Population Pharmacokinetics/Pharmacodynamics of Ticagrelor in Children with Sickle Cell Disease

   • Carl Amilon
   • Mohammad Niazi
   • Bengt Hamrén

   Original Research Article 11 April 2019 Pages: 1295 - 1307

   

6. Population Pharmacokinetics of Risankizumab in Healthy Volunteers and Subjects with Moderate to Severe Plaque Psoriasis: Integrated Analyses of Phase I–III Clinical Trials

   • Ahmed A. Suleiman
   • Mukul Minocha
   • Ahmed A. Othman

   Original Research Article Open access 04 May 2019 Pages: 1309 - 1321

   

7. Optimizing Estimated Glomerular Filtration Rate to Support Adult to Pediatric Pharmacokinetic Bridging Studies in Patients with Cystic Fibrosis

   • Ryan L. Crass
   • Manjunath P. Pai

   Original Research Article 10 April 2019 Pages: 1323 - 1332

   

8. A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients

   • Cornelis Smit
   • Roeland E. Wasmann
   • Catherijne A. J. Knibbe

   Original Research Article Open access 24 April 2019 Pages: 1333 - 1343

   

9. Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis

   • Dario Cattaneo
   • Sara Baldelli
   • Cristina Gervasoni

   Short Communication 04 April 2019 Pages: 1345 - 1350

10. Comment on: “Levothyrox^® New and Old Formulations: Are they Switchable for Millions of Patients?”

    • Philippe Lechat
    • Jacques Ropers
    • Stephane Mouly

    Letter to the Editor 27 August 2019 Pages: 1351 - 1352

11. Authors’ Reply to Lechat et al.: “Levothyrox^® New and Old Formulations: Are they Switchable for Millions of Patients?”

    • Didier Concordet
    • Peggy Gandia
    • Pierre-Louis Toutain

    Letter to the Editor Open access 27 August 2019 Pages: 1353 - 1354